字号·· | 护眼
CNBC

以下是周四最受关注的分析师评级:英伟达、SpaceX、AMD、苹果、Ulta、迪士尼等Here are Thursday's biggest analyst calls: Nvidia, SpaceX, AMD, Apple, Ulta, Disney & more

点「原文对照」整页切到原文,或双击某段只看那段的原文。

以下是周四华尔街最重要的评级变动:伯恩斯坦重申苹果“跑赢大盘”评级伯恩斯坦表示该股估值倍数“合理”。“AAPL的估值倍数离谱吗?考虑到其客户忠诚度、盈利持久性、增长、自由现金流产生能力及股东回报,我们不认为如此。我们的反向DCF模型隐含终值增长率为4%,这看起来合理。”派博沙勒将通用磨坊从“增持”降级至“中性”派博沙勒称看到“经营压力”。

Here are the biggest calls on Wall Street on Thursday: Bernstein reiterates Apple as outperform Bernstein says the stock's multiple is "reasonable." "Is AAPL' s multiple outrageous? Considering its customer loyalty, earnings durability, growth, FCF generation and shareholder returns, we don't think so. Our reverse DCF implies a terminal growth rate of 4%, which appears reasonable." Piper Sandler downgrades General Mills to neutral from overweight Piper says it sees "operating pressures."

“我们将GIS降级至中性,因为我们现在看到其股息水平面临风险,同时持续面临经营压力。”巴克莱将Reliance从“等权重”升级至“增持”巴克莱上调这家钢铁公司评级,称预期钢价上涨。“我们将RS从等权重升级至增持,反映了基于供应收紧、销量增强及利润率改善,对2027/28财年预期的上调。”奥本海默将英伟达从“跑赢大盘”降级至“表现与大盘一致”该机构因英伟达内部动荡加剧而下调评级。

"We downgrade GIS to Neutral, as we now see risk to its dividend level, along with ongoing operating pressures." Barclays upgrades Reliance to overweight from equal weight Barclays upgraded the steel company and says it sees higher steel prices. "We upgrade RS to Overweight from Equal Weight, reflecting higher 2027/28 estimates on tighter supply, stronger volumes and margins." Oppenheimer downgrades Nvidia to perform from outperform The firm downgraded the stock due to the increasing turmoil at Nvidia.

“鉴于《华尔街日报》、《纽约时报》报道创始CEO黄仁勋因第二桩婚外情指控即将离职,我们下调NVDA评级并撤回目标价。”伯恩斯坦将英伟达从“跑赢大盘”降级至“跟随大盘”伯恩斯坦周三晚间在致客户研报中称别无选择,只能下调该股评级。“我们承认在这个评级决定上极其挣扎,能理解逢低买入的理由。但我们的直觉告诉我们,可能尚未完全探明此事的深度;我们已受够,更倾向于在场外观望。”

"We are downgrading shares of NVDA and removing our price target following reports (WSJ, NYT) of founding CEO Jensen Huang's imminent departure amidst allegations of a 2nd extramarital affair." Bernstein downgrades Nvidia to market perform from outperform Bernstein said in a note to clients late Wednesday night that it had no choice but to downgrade the stock. "We admit to struggling mightily with this call, and can sympathize with the case to buy the dip. But our gut tells us that we probably haven't yet fully probed the depths of what might be found here; we've had enough, and prefer to watch from the sidelines."

KeyBanc将Maravai Lifesciences从“板块权重”升级至“增持”KeyBanc称该公司是中期选举的赢家。“特朗普政府及RFK Jr.担任HHS部长是MRVI及其mRNA技术最坏的结果。例如,HHS叫停了5亿美元已获资助的mRNA项目,并对基于mRNA的疫苗和疗法前景提出质疑。”

KeyBanc upgrades Maravai Lifesciences to overweight sector weight Key says the company is a midterms winner. "The Trump Administration and RFK Jr. as Head of HHS was the worst outcome possible for MRVI and its mRNA technology. For example, HHS halted $500M of funded mRNA programs and raised concern over the future of mRNA based vaccines and therapies.

与此同时,MRVI 也在新管理层(6/9/25)的带领下进行了重组,并将年度化开支削减了 6500 万美元以上。William Blair 将超微半导体评级从“跟随大盘”上调至“跑赢大盘” William Blair 表示,AMD 可从英伟达的动荡中受益。“与此同时,英伟达面临更严格的审查和潜在的领导层真空,虽然 ASIC 竞争仍对 Instinct 构成风险(特别是在 Meta [META 628.07 美元;跑赢大盘] 和 OpenAI),但我们看到 AMD 有机会从定制项目中受益,作为 CPU 搭售的机会。”

Meanwhile, MRVI has also reorganized with new management (6/9/25) and reduced annualized expenses by +$65M." William Blair upgrades Advanced Micro Devices to outperform from market perform William Blair says AMD can benefit from the turmoil at Nvidia. "Meanwhile, Nvidia is facing increased scrutiny and a potential leadership vacuum, and while ASIC competition remains a risk to Instinct (particularly at Meta [META $628.07; Outperform] and OpenAI), we see an opportunity for AMD to benefit from custom programs as an opportunity for CPU attach."

Roth 以“买入”评级启动覆盖 Kimball Electronics Roth 表示,这家安全关键型电子产品制造商拥有充足的上涨空间。“我们以买入评级和 37 美元目标价启动对 Kimball Electronics 的覆盖。” BTIG 以“买入”评级启动覆盖 Quantinuum BTIG 表示,该股极具吸引力。“我们以买入评级和 60.00 美元目标价启动对 Quantinuum (QNT) 的覆盖,视其为该领域当前的质量领导者,交易价格较同业存在我们认为不合理的折价。”

Roth initiates Kimball Electronics as buy Roth says the safety-critical electronics manufacturer has plenty of upside. "We initiate coverage o f Kimball Electronics with a Buy rating and $37 price target." BTIG initiates Quantinuum as buy BTIG says shares are compelling. "We initiate coverage of Quantinuum (QNT) at BUY with a $60.00 Price Target, viewing the company as the current quality leader in the sector trading at what we believe is an unwarranted discount to peers."

Jefferies 以“买入”评级启动覆盖 Pattern Group Jefferies 表示,这家电商管理公司处于有利位置,可实现增长。“PTRN 在现有品牌客户中交付高增长的记录,现在正由新品牌的更大贡献来补充。” 富国银行将 Engene 评级从“等权重”上调至“超配” 富国表示,对这家生物技术公司“信心增强”。“我们将 ENGN 评级从 EW 上调至 OW,并将目标价从 2 美元上调至 6 美元。”

Jefferies initiates Pattern Group as buy Jefferies says the ecommerce management company is well positioned for growth. "PTRN's track record of delivering elevated growth across existing brand customers is now being complemented by larger contributions from new brands." Wells Fargo upgrades Engene to overweight from equal weight Wells says it has "increasing confidence" in the biotech company. "We upgrade ENGN to OW from EW and raise our PT to $6 from $2."

UBS 以“买入”评级启动覆盖 Ensysce Biosciences UBS 表示,这家生物技术公司拥有独特的产品。“我们以买入评级和 2 美元/股目标价启动对 Ensysce Biosciences (ENSC) 的覆盖,反映出我们看到的处于早期但具有差异化的慢性疼痛机会。” 巴克莱以“超配”评级启动覆盖 Dorman Products 巴克莱表示,预见这家汽车售后市场公司将迎来一系列积极催化剂。

UBS initiates Ensysce Biosciences as buy UBS says the biotech company has a unique offering. "We initiate coverage of Ensysce Biosciences (ENSC) with a Buy rating and $2/sh PT, reflecting what we see as an early-stage but differentiated opportunity in chronic pain." Barclays initiates Dorman Products as overweight Barclays says it sees a slew of positive catalysts ahead for the auto aftermarket company.

“DORM 似乎处于有利位置,可在 2028 年前实现营收增长 4% 至 5% 或更多,增速超过我们覆盖的大多数美国汽车零售股,并处于汽车售后市场零售商的高端水平。”美国银行将维多利亚的秘密评级从“买入”下调至“中性”美国银行表示,维多利亚的秘密“每股收益上行空间有限”。“随着股价今年以来大幅上涨,我们关于品牌扭转将推动盈利预期上调的投资逻辑已兑现,因此我们将评级从‘买入’下调至‘中性’。”

" DORM looks well positioned to grow revenues +4-5% or more through 2028, outpacing most of our US Auto Retail coverage and at the upper end of the auto aftermarket retailers." Bank of America downgrades Victoria's Secret to neutral from buy Bank of America says it sees "limited EPS upside" for Victoria's Secret. "With the stock up meaningfully YTD, our thesis of upward estimate revisions driven by the brand turnaround has played out, and we are downgrading from Buy to Neutral."

奥本海默重申 SpaceX “跑赢大盘”评级奥本海默表示,SpaceX 仍对大型电信运营商构成威胁。“SPCX 是房间里那头 2 万亿美元的大象,随着其地面野心愈发清晰(高通合作),现有巨头依然不屑一顾和/或低估了其潜在的上市速度。”德意志银行重申 Ulta Beauty “买入”评级德意志银行将目标价从每股 671 美元上调至 723 美元。

Oppenheimer reiterates SpaceX as outperform Oppenheimer says SpaceX remains a risk to big telecom. SPCX is the $2T elephant in the room with its terrestrial ambitions growing clearer (QCOM partnership) as incumbents remain dismissive and/or are underestimating potential speed-to-market." Deutsche Bank reiterates Ulta as buy Deutsche raised its price target to $723 per share from $671.

“我们相信 ULTA 第三季度业绩将提供另一佐证,证明其销售势头的持久性和质量,尽管面临更艰难的同比基数和日益激烈的美妆竞争环境。”Evercore ISI 重申迪士尼 “跑赢大盘”评级Evercore 表示,迪士尼股价需要做得更多才能“突破”。“展望未来,为了让股价突破,我们认为叙事需要在以下三个方面之一或多方面迎来催化剂:(1) 产品周期;(2) 内容周期;或 (3) 盈利增长曲线的阶梯式改善。”

"We believe ULTA's 3 Q results can provide another proof point on the durability and quality of its sales momentum despite tougher comparisons and an increasingly competitive beauty environment." Evercore ISI reiterates Disney as outperform Evercore says Disney shares needs to do more in order to "break out." "Looking ahead, for shares to break out, we think the narrative needs a catalyst on one or more of three fronts: (1) a product cycle; (2) a content cycle; or (3) a step-function improvement in the earnings growth curve."

阅读媒体原文 ↗